 In addition the study will capture reported bleed rate, pattern of change in KOVALTRY prophylaxis dose dosing frequency, reason for choice of treatment regimen, FVIII product switch pattern, patient treatment satisfaction and adherence, KOVALTRY pharmacokinetic data if performed, KOVALTRY consumption, as well as safety data. 